Endocrine Responses to Critical Illness: Novel Insights and Therapeutic Implications
The DOI matches its Crossref record; 162 of the 164 references it cites were found in a registry or an index.
Abstract
CONTEXT: Critical illness, an extreme form of severe physical stress, is characterized by important endocrine and metabolic changes. Due to critical care medicine, survival from previously lethal conditions has become possible, but many patients now enter a chronic phase of critical illness. The role of the endocrine and metabolic responses to acute and prolonged critical illness in mediating or hampering recovery remains highly debated. EVIDENCE ACQUISITION: The recent literature on changes within the hypothalamic-pituitary-thyroid axis and the hypothalamic-pituitary-adrenal axis and on hyperglycemia in relation to recovery from critical illness was critically appraised and interpreted against previous insights. Possible therapeutic implications of the novel insights were analyzed. Specific remaining questions were formulated. EVIDENCE SYNTHESIS: In recent years, important novel insights in the pathophysiology and the consequences of some of these endocrine responses to acute and chronic critical illness were generated. Acute endocrine adaptations are directed toward providing energy and substrates for the vital fight-or-flight response in a context of exogenous substrate deprivation. Distinct endocrine and metabolic alterations characterize the chronic phase of critical illness, which seems to be no longer solely beneficial and could hamper recovery and rehabilitation. CONCLUSIONS: Important novel insights reshape the current view on endocrine and metabolic responses to critical illness and further clarify underlying pathways. Although many issues remain unresolved, some therapeutic implications were already identified. More work is required to find better treatments, and the optimal timing for such treatments, to further prevent protracted critical illness, to enhance recovery thereof, and to optimize rehabilitation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prolonged reduction of ACTH signaling within adrenocortical cells may result in adrenal atrophy [59].”
In the citing paper
“Post-mortem studies of patients who died after prolonged sepsis demonstrate reduced adrenal cortical size and changes in adrenal morphology in keeping with reduced exposure of the adrenal cortex to ACTH [59].”
In the citing paper
“In addition, feedback inhibition exerted by elevated circulating free cortisol, driven by ACTH-independent mechanisms and suppressed cortisol breakdown, can suppress ACTH [14,15,59].”
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 3×
“The study revealed that blood glucose control to a normoglycemic target increased mortality as compared with the intermediate level in the control group (116), subsequently explained by a 13-fold increase in hypoglycemia (117).”
BackgroundResultIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“In a second study performed in patients admitted to a medical ICU in Leuven, these morbidity benefits were confirmed (106).”
BackgroundAnnane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Acute skeletal muscle wasting in critical illness
Puthucheary, Z. A., Rawal, J., McPhail, M., Connolly, B., Ratnayake, G., Chan, P., Hopkinson, N. S., Padhke, R., Dew, T., Sidhu, P. S., et al. (2013) · JAMA · doi:10.1001/jama.2013.278481 · Cited by 2,103
ESPEN guidelines on parenteral nutrition: intensive care
Singer, P., Berger, M. M., Van den Berghe, G., Biolo, G., Calder, P., Forbes, A., Griffiths, R., Kreyman, G., Leverve, X., & Pichard, C. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.04.024 · Cited by 1,907
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
Early versus late parenteral nutrition in critically ill adults
Casaer, M. P., Mesotten, D., Hermans, G., Wouters, P. J., Schetz, M., Meyfroidt, G., Van Cromphaut, S., Ingels, C., Meersseman, P., Muller, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102662 · Cited by 1,696
Van den Berghe, G., Wouters, P. J., Bouillon, R., Weekers, F., Verwaest, C., Schetz, M., Vlasselaers, D., Ferdinande, P., & Lauwers, P. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000045568.12881.10 · Cited by 1,455
Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult Patients
Krinsley, J. S. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.8.992 · Cited by 1,223
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009
Annane, D. (2000) · JAMA · doi:10.1001/jama.283.8.1038 · Cited by 1,000 · cited 1×
“From large association studies, such a condition is thought to be identifiable by an insufficient rise ( 9 g/dL) in plasma cortisol in response to a 250- g ACTH bolus, irrespective of the baseline plasma cortisol concentration, which is usually much higher than in healthy humans (72).”
BackgroundNegative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients
Villet, S., Chiolero, R. L., Bollmann, M. D., Revelly, J.-P., Cayeux RN, M.-C., Delarue, J., & Berger, M. M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2005.03.006 · Cited by 995
Marik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912 · cited 1×
“Alternatively, a random total cortisol of 10 g/dL during critical illness has been suggested for the diagnosis of “relative adrenal insufficiency” (75).”
BackgroundPreiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
Briegel, J., Forst, H., Haller, M., Schelling, G., Kilger, E., Kuprat, G., Hemmer, B., Hummel, T., Lenhart, A., Heyduck, M., et al. (1999) · Critical Care Medicine · doi:10.1097/00003246-199904000-00025 · Cited by 889
Reversal of late septic shock with supraphysiologic doses of hydrocortisone
Bollaert, P.-E., Charpentier, C., Levy, B., Debouverie, M., Audibert, G., & Larcan, A. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00010 · Cited by 872
Measurements of Serum Free Cortisol in Critically Ill Patients
Hamrahian, A. H., Oseni, T. S., & Arafah, B. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa020266 · Cited by 726
Kosiborod, M., Rathore, S. S., Inzucchi, S. E., Masoudi, F. A., Wang, Y., Havranek, E. P., & Krumholz, H. M. (2005) · Circulation · doi:10.1161/circulationaha.104.517839 · Cited by 666
Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units
Van den Berghe, G., Wilmer, A., Milants, I., Wouters, P. J., Bouckaert, B., Bruyninckx, F., Bouillon, R., & Schetz, M. (2006) · Diabetes · doi:10.2337/db06-0855 · Cited by 599
Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis
Falciglia, M., Freyberg, R. W., Almenoff, P. L., D’Alessio, D. A., & Render, M. L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b083f7 · Cited by 576
Vlasselaers, D., Milants, I., Desmet, L., Wouters, P. J., Vanhorebeek, I., van den Heuvel, I., Mesotten, D., Casaer, M. P., Meyfroidt, G., Ingels, C., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60044-1 · Cited by 554 · cited 2×
“A subsequent randomized controlled study was performed in critically ill children, in which the intervention group was targeted to normal fasting glucose levels for the age groups (50–80 mg/dL for infants, and 70–100 mg/dL for children) as compared with tolerating hyperglycemia up to 215 mg/dL (107).”
BackgroundTumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans
DAMAS, P., REUTER, A., GYSEN, P., DEMONTY, J., LAMY, M., & FRANCHIMONT, P. (1989) · Critical Care Medicine · doi:10.1097/00003246-198910000-00001 · Cited by 486
Reduced Cortisol Metabolism during Critical Illness
Boonen, E., Vervenne, H., Meersseman, P., Andrew, R., Mortier, L., Declercq, P. E., Vanwijngaerden, Y.-M., Spriet, I., Wouters, P. J., Vander Perre, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214969 · Cited by 477 · cited 7×
“Furthermore, the sc adipose tissue is not the main target tissue for cortisol, nor is it the main cortisol-metabolizing organ during critical illness (62).”
BackgroundResultInfluentialSelf-citationIntensive insulin therapy protects the endothelium of critically ill patients
Langouche, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25385 · Cited by 467
Thyroid Hormone Treatment after Coronary-Artery Bypass Surgery
Klemperer, J. D., Klein, I., Gomez, M., Helm, R. E., Ojamaa, K., Thomas, S. J., Isom, O. W., & Krieger, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332302 · Cited by 460
Vanhorebeek, I., De Vos, R., Mesotten, D., Wouters, P. J., De Wolf-Peeters, C., & Van den Berghe, G. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17665-4 · Cited by 452
Suh, S. W., Gum, E. T., Hamby, A. M., Chan, P. H., & Swanson, R. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30077 · Cited by 419
American College of Endocrinology Position Statement on Inpatient Diabetes and Metabolic Control
Garber, A. J., Moghissi, E. S., Bransome, E. D., Clark, N. G., Clement, S., Cobin, R. H., Furnary, A. P., Hirsch, I. B., Levy, P., Roberts, R., et al. (2004) · Endocrine Practice · doi:10.4158/ep.10.s2.4 · Cited by 409
Krinsley, J. S., Egi, M., Kiss, A., Devendra, A. N., Schuetz, P., Maurer, P. M., Schultz, M. J., van Hooijdonk, R. T., Kiyoshi, M., Mackenzie, I. M., et al. (2013) · Critical Care · doi:10.1186/cc12547 · Cited by 369
Hermans, G., Wilmer, A., Meersseman, W., Milants, I., Wouters, P. J., Bobbaers, H., Bruyninckx, F., & Van den Berghe, G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-665oc · Cited by 368 · cited 1×
“Treating critically ill patients with glucocorticoids in too high of a dose for too long of a period could inferentially aggravate the loss of lean tissue, increase the risk of myopathy, and prolong the ICU dependence, which could increase the susceptibility to potentially lethal complications (93, 94).”
BackgroundHyperglycemic kidney damage in an animal model of prolonged critical illness
Vanhorebeek, I., Gunst, J., Ellger, B., Boussemaere, M., Lerut, E., Debaveye, Y. A., Rabbani, N., Thornalley, P. J., Schetz, M., & den Berghe, G. V. (2009) · Kidney International · doi:10.1038/ki.2009.217 · Cited by 368
BRENT, G. A., & HERSHMAN, J. M. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-1-1 · Cited by 365
Toward Understanding Tight Glycemic Control in the ICU
Marik, P. E., & Preiser, J.-C. (2010) · Chest · doi:10.1378/chest.09-1737 · Cited by 365
Kosiborod, M. (2009) · JAMA · doi:10.1001/jama.2009.496 · Cited by 364
Hermans, G., Casaer, M. P., Clerckx, B., Güiza, F., Vanhullebusch, T., Derde, S., Meersseman, P., Derese, I., Mesotten, D., Wouters, P. J., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70183-8 · Cited by 364
Wintergerst, K. A., Buckingham, B., Gandrud, L., Wong, B. J., Kache, S., & Wilson, D. M. (2006) · Pediatrics · doi:10.1542/peds.2005-1819 · Cited by 360
Dissociation of ACTH and glucocorticoids
Bornstein, S. R., Engeland, W. C., Ehrhart-Bornstein, M., & Herman, J. P. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.01.009 · Cited by 345
Clinical review: Critical illness polyneuropathy and myopathy
Hermans, G., De Jonghe, B., Bruyninckx, F., & Berghe, G. (2008) · Critical Care · doi:10.1186/cc7100 · Cited by 320
Endocrinology: Adult and Pediatric
(2016) · Elsevier eBooks · doi:10.1016/c2012-1-03052-4 · Cited by 308
Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118353 · Cited by 287
Beyond Low Plasma T3: Local Thyroid Hormone Metabolism during Inflammation and Infection
Boelen, A., Kwakkel, J., & Fliers, E. (2011) · Endocrine Reviews · doi:10.1210/er.2011-0007 · Cited by 287
American College of Endocrinology Position Statement on Inpatient Diabetes and Metabolic Control
Garber, A. J., Moghissi, E. S., Bransome, E. D., Clark, N. G., Clement, S., Cobin, R. H., Furnary, A. P., Hirsch, I. B., Levy, P., Robert, R., et al. (2004) · Endocrine Practice · doi:10.4158/ep.10.1.77 · Cited by 284
Tight Glycemic Control versus Standard Care after Pediatric Cardiac Surgery
Agus, M. S. D., Steil, G. M., Wypij, D., Costello, J. M., Laussen, P. C., Langer, M., Alexander, J. L., Scoppettuolo, L. A., Pigula, F. A., Charpie, J. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206044 · Cited by 274
Peeters, R. P., Wouters, P. J., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0535 · Cited by 251 · cited 1×
“In critical illness, it was suggested that the low T3 concentrations could be maladaptive because the magnitude of the acute T3 decrease was associated with the severity of illness and with the risk of death (17, 18).”
BackgroundVermes, I. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1238 · Cited by 249
Weekers, F., Giulietti, A.-P., Michalaki, M., Coopmans, W., Van Herck, E., Mathieu, C., & Van den Berghe, G. (2003) · Endocrinology · doi:10.1210/en.2003-0697 · Cited by 245
Bilotta, F., Spinelli, A., Giovannini, F., Doronzio, A., Delfini, R., & Rosa, G. (2007) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0b013e3180338e69 · Cited by 243
Insufficient Activation of Autophagy Allows Cellular Damage to Accumulate in Critically Ill Patients
Vanhorebeek, I., Gunst, J., Derde, S., Derese, I., Boussemaere, M., Güiza, F., Martinet, W., Timmermans, J.-P., D'Hoore, A., Wouters, P. J., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2563 · Cited by 241 · cited 5×
“2013-4115 J Clin Endocrinol Metab, May 2014, 99(5):1569–1582 jcem.”
BackgroundMethodInfluentialEffect of Tri-Iodothyronine Replacement on the Metabolic and Pituitary Responses to Starvation
Gardner, D. F., Kaplan, M. M., Stanley, C. A., & Utiger, R. D. (1979) · New England Journal of Medicine · doi:10.1056/nejm197903153001102 · Cited by 239
Van den Berghe, G., Wouters, P., Weekers, F., Mohan, S., Baxter, R. C., Veldhuis, J. D., Bowers, C. Y., & Bouillon, R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5636 · Cited by 233
Survival Benefits of Intensive Insulin Therapy in Critical Illness
Ellger, B., Debaveye, Y., Vanhorebeek, I., Langouche, L., Giulietti, A., Van Etten, E., Herijgers, P., Mathieu, C., & Van den Berghe, G. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1434 · Cited by 221
Prediction of outcome in intensive care patients using endocrine parameters
Rothwell, P. M., & Lawler, P. G. (1995) · Critical Care Medicine · doi:10.1097/00003246-199501000-00015 · Cited by 219
Intensive Insulin Therapy in Severely Burned Pediatric Patients: A Prospective Randomized Trial
Jeschke, M. G., Kulp, G. A., Kraft, R., Finnerty, C. C., Mlcak, R., Lee, J. O., & Herndon, D. N. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0190oc · Cited by 212
Finfer, S., Wernerman, J., Preiser, J.-C., Cass, T., Desaive, T., Hovorka, R., Joseph, J. I., Kosiborod, M., Krinsley, J., Mackenzie, I., et al. (2013) · Critical Care · doi:10.1186/cc12537 · Cited by 208
Fliers, E., Guldenaar, S. E. F., Wiersinga, W. M., & Swaab, D. F. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4404 · Cited by 206 · cited 1×
“In line with this interpretation, Fliers et al (26) demonstrated in postmortem brain samples of chronic critically ill patients that the gene expression of TRH in the hypothalamic paraventricular nuclei was much lower than in patients who died after acute insults (Figure 1).”
ResultHypermetabolic low triiodothyronine syndrome of burn injury
BECKER, R. A., VAUGHAN, G. M., ZIEGLER, M. G., SERAILE, L. G., GOLDFARB, I. W., MANSOUR, E. H., McMANUS, W. F., PRUITT, B. A., & MASON, A. D. (1982) · Critical Care Medicine · doi:10.1097/00003246-198212000-00014 · Cited by 205
Kavanagh, B. P., & McCowen, K. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001115 · Cited by 205 · cited 1×
“dated for critically ill patients (124).”
Van den Berghe, G., de Zegher, F., Baxter, R. C., Veldhuis, J. D., Wouters, P., Schetz, M., Verwaest, C., Van der Vorst, E., Lauwers, P., Bouillon, R., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4575 · Cited by 204
The Relationship between Serum Triiodothyronine and Thyrotropin during Systemic Illness*
BACCI, V., SCHUSSLER, G. C., & KAPLAN, T. B. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-6-1229 · Cited by 202
Van den Berghe, G., Wouters, P. J., Kesteloot, K., & Hilleman, D. E. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000201408.15502.24 · Cited by 201
Ingels, C., Debaveye, Y., Milants, I., Buelens, E., Peeraer, A., Devriendt, Y., Vanhoutte, T., Van Damme, A., Schetz, M., Wouters, P. J., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi855 · Cited by 191
Cost Analysis of Intensive Glycemic Control in Critically Ill Adult Patients
Stephen Krinsley, J., & Jones, R. L. (2006) · Chest · doi:10.1378/chest.129.3.644 · Cited by 185
Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial
Kalfon, P., Giraudeau, B., Ichaï, C., Guerrini, A., Bréchot, N., Cinotti, R., Dequin, P., Riu-Poulenc, B., Montravers, P., Annane, D., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3189-0 · Cited by 175
A trial of thyroxine in acute renal failure
Acker, C. G., Singh, A. R., Flick, R. P., Bernardini, J., Greenberg, A., & Johnson, J. P. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00827.x · Cited by 174
Dopamine and the sick euthyroid syndrome in critical illness
Van den Berghe, G., de Zegher, F., & Lauwers, P. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02787.x · Cited by 169
Wajner, S. M., Goemann, I. M., Bueno, A. L., Larsen, P. R., & Maia, A. L. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44678 · Cited by 168
Van den Berghe, G. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.309 · Cited by 164
Self-citationVan den Berghe, G., De Zegher, F., Veldhuis, J. D., Wouters, P., Gouwy, S., Stockman, W., Weekers, F., Schetz, M., Lauwers, P., Bouillon, R., et al. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.3371118.x · Cited by 163
Tight glucose control in the intensive care unit: Are glucose meters up to the task?
Scott, M. G., Bruns, D. E., Boyd, J. C., & Sacks, D. B. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.117291 · Cited by 162
Safety and Efficacy of Intensive Insulin Therapy in Critical Neurosurgical Patients
Bilotta, F., Caramia, R., Paoloni, F. P., Delfini, R., & Rosa, G. (2009) · Anesthesiology · doi:10.1097/aln.0b013e318198004b · Cited by 161
Low Serum Triiodothyronine in Patients with Anorexia Nervosa
MOSHANG, T., PARKS, J. S., BAKER, L., VAIDYA, V., UTIGER, R. D., BONGIOVANNI, A. M., & SNYDER, P. J. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-3-470 · Cited by 160
Gunst, J., Derese, I., Aertgeerts, A., Ververs, E.-J., Wauters, A., Van den Berghe, G., & Vanhorebeek, I. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182676657 · Cited by 160
Boelen, A., Kwakkel, J., Thijssen-Timmer, D., Alkemade, A., Fliers, E., & Wiersinga, W. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1820315 · Cited by 159
Mesotten, D., Gielen, M., Sterken, C., Claessens, K., Hermans, G., Vlasselaers, D., Lemiere, J., Lagae, L., Gewillig, M., Eyskens, B., et al. (2012) · JAMA · doi:10.1001/jama.2012.12424 · Cited by 153
Prigent, H., Maxime, V., & Annane, D. (2004) · Critical Care · doi:10.1186/cc2878 · Cited by 151
SERUM CORTISOL LEVELS IN SEVERELY STRESSED PATIENTS
Finlay, W. I., & Mckee, J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92531-4 · Cited by 146
Casaer, M. P., Langouche, L., Coudyzer, W., Vanbeckevoort, D., De Dobbelaer, B., Güiza, F. G., Wouters, P. J., Mesotten, D., & Van den Berghe, G. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828cef02 · Cited by 145
Tissue Thyroid Hormone Levels in Critical Illness
Peeters, R. P., van der Geyten, S., Wouters, P. J., Darras, V. M., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1013 · Cited by 145
CHOPRA, I. J., HUANG, T.-S., BEREDO, A., SOLOMON, D. H., TECO, G. N. C., & MEAD, J. F. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-4-666 · Cited by 143
Endocrine aspects of acute and prolonged critical illness
Vanhorebeek, I., Langouche, L., & Van den Berghe, G. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0071 · Cited by 141
Mullis, S. L., Argenziano, M., Corwin, S., Homma, S., Weinberg, A. D., Williams, M., Rose, E. A., & Smith, C. R. (1999) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70249-7 · Cited by 140
Dopamine suppresses pituitary function in infants and children
den Berghe, G. V., de Zegher, F., & Lauwers, P. (1995) · Pediatric Nephrology · doi:10.1007/bf00866735 · Cited by 138
Adrenal Insufficiency in the Surgical Intensive Care Unit Patient
Barquist, E., & Kirton, O. (1997) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199701000-00006 · Cited by 137
Van den Berghe, G., Baxter, R. C., Weekers, F., Wouters, P., Bowers, C. Y., Iranmanesh, A., Veldhuis, J. D., & Bouillon, R. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01255.x · Cited by 134
Ledderose, C., Möhnle, P., Limbeck, E., Schütz, S., Weis, F., Rink, J., Briegel, J., & Kreth, S. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825b8ebc · Cited by 130
Dopamine suppresses pituitary function in infants and children
Van den Berghe, G., de Zegher, F., & Lauwers, P. (1994) · Critical Care Medicine · doi:10.1097/00003246-199422110-00008 · Cited by 128
Pugeat, M., Bonneton, A., Perrot, D., Rocle-Nicolas, B., Lejeune, H., Grenot, C., Déchaud, H., Brébant, C., Motin, J., & Cuilleron, C. Y. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.8.1675 · Cited by 121
Decreased Nocturnal Surge of Thyrotropin in Nonthyroidal Illness*
ROMIJN, J. A., & WIERSINGA, W. M. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-1-35 · Cited by 117
Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure
Redout, E. M., van der Toorn, A., Zuidwijk, M. J., van de Kolk, C. W. A., van Echteld, C. J. A., Musters, R. J. P., van Hardeveld, C., Paulus, W. J., & Simonides, W. S. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00097.2009 · Cited by 117
The hypothalamus-pituitary-thyroid axis in critical illness.
Mebis, L., & den Berghe, G. V. (2009) · PubMed · Cited by 116
Hauer, D., Weis, F., Papassotiropoulos, A., Schmoeckel, M., Beiras-Fernandez, A., Lieke, J., Kaufmann, I., Kirchhoff, F., Vogeser, M., Roozendaal, B., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206bae6 · Cited by 115
Lim, C. F. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1165 · Cited by 113
Relative eosinophilla and functional adrenal insufficiency in critically ill patients
Beishuizen, A., Vermes, I., Hylkema, B. S., & Haanen, C. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01346-x · Cited by 112
Mebis, L., Langouche, L., Visser, T. J., & Van den Berghe, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0510 · Cited by 101 · cited 2×
“Also, in skeletal muscle biopsies from prolonged critically ill patients, D2 expression and activity were up-regulated as compared with healthy controls and with acutely ill patients (Figure 1) (37).”
BackgroundResultManagement of Hypothyroidism and Hyperthyroidism in the Intensive Care Unit
Ringel, M. D. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70152-4 · Cited by 99
Thyroid axis function and dysfunction in critical illness
Mebis, L., & Van den Berghe, G. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.03.002 · Cited by 99 · cited 1×
“2011;25:745– 757 (126), with permission.”
Faglia, G., Ferrari, C., Beck-Peccoz, P., Spada, A., Travaglini, P., & Ambrosi, B. (1973) · Hormone and Metabolic Research · doi:10.1055/s-0028-1093930 · Cited by 98
Expression of thyroid hormone transporters during critical illness
Mebis, L., Paletta, D., Debaveye, Y., Ellger, B., Langouche, L., D'Hoore, A., Darras, V. M., Visser, T. J., & Van den Berghe, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0290 · Cited by 97
Olveira, G., Tapia, M. J., Ocón, J., Cabrejas-Gómez, C., Ballesteros-Pomar, M. D., Vidal-Casariego, A., Arraiza-Irigoyen, C., Olivares, J., Conde-García, M. D. C., García-Manzanares, Á., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1379 · Cited by 97
Vanwijngaerden, Y.-M., Wauters, J., Langouche, L., Vander Perre, S., Liddle, C., Coulter, S., Vanderborght, S., Roskams, T., Wilmer, A., Van den Berghe, G., et al. (2011) · Hepatology · doi:10.1002/hep.24582 · Cited by 96
15-Year Follow-Up of Recurrent “Hypoglycemia” in Preterm Infants
Tin, W., Brunskill, G., Kelly, T., & Fritz, S. (2012) · Pediatrics · doi:10.1542/peds.2012-0776 · Cited by 96
Michalaki, M., Vagenakis, A. G., Makri, M., Kalfarentzos, F., & Kyriazopoulou, V. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7795 · Cited by 95
LOGIC-Insulin Algorithm–Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness
Van Herpe, T., Mesotten, D., Wouters, P. J., Herbots, J., Voets, E., Buyens, J., De Moor, B., & Van den Berghe, G. (2013) · Diabetes Care · doi:10.2337/dc12-0584 · Cited by 95
Ahrens, C. L., Barletta, J. F., Kanji, S., Tyburski, J. G., Wilson, R. F., Janisse, J. J., & Devlin, J. W. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000186746.64572.8a · Cited by 93
McNeilly, A. D., Macfarlane, D. P., O’Flaherty, E., Livingstone, D. E., Mitić, T., McConnell, K. M., McKenzie, S. M., Davies, E., Reynolds, R. M., Thiesson, H. C., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.037 · Cited by 90
van der Poll, T., Van Zee, K. J., Endert, E., Coyle, S. M., Stiles, D. M., Pribble, J. P., Catalano, M. A., Moldawer, L. L., & Lowry, S. F. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7714108 · Cited by 85 · cited 1×
“failed to restore normal thyroid hormone concentrations (13).”
BackgroundCohen, J., Ward, G., Prins, J., Jones, M., & Venkatesh, B. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0389-x · Cited by 83
Mebis, L., Debaveye, Y., Ellger, B., Derde, S., Ververs, E.-J., Langouche, L., Darras, V. M., Fliers, E., Visser, T. J., & Van den Berghe, G. (2009) · Critical Care · doi:10.1186/cc8043 · Cited by 82 · cited 1×
“However, the hypothalamic T4 and T3 concentrations were not increased (33).”
BackgroundHow Changes in Affinity of Corticosteroid-binding Globulin Modulate Free Cortisol Concentration
Chan, W. L., Carrell, R. W., Zhou, A., & Read, R. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4280 · Cited by 82
Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis
van den Akker, E. L. T., Koper, J. W., Joosten, K., de Jong, F. H., Hazelzet, J. A., Lamberts, S. W. J., & Hokken-Koelega, A. C. S. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1468-6 · Cited by 81
Vanhorebeek, I., Ellger, B., De Vos, R., Boussemaere, M., Debaveye, Y., Perre, S. V., Rabbani, N., Thornalley, P. J., & Van den Berghe, G. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819cec17 · Cited by 79
Langouche, L., Vander Perre, S., Marques, M., Boelen, A., Wouters, P. J., Casaer, M. P., & Van den Berghe, G. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2809 · Cited by 79
Impact of Duration of Critical Illness on the Adrenal Glands of Human Intensive Care Patients
Boonen, E., Langouche, L., Janssens, T., Meersseman, P., Vervenne, H., De Samblanx, E., Pironet, Z., Van Dijck, L., Vander Perre, S., Derese, I., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2429 · Cited by 75
Self-citationReduced nocturnal ACTH-driven cortisol secretion during critical illness
Boonen, E., Meersseman, P., Vervenne, H., Meyfroidt, G., Guïza, F., Wouters, P. J., Veldhuis, J. D., & Van den Berghe, G. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00009.2014 · Cited by 75
Self-citationGuerrero, J., Gatica, H. A., Rodríguez, M., Estay, R., & Goecke, I. A. (2013) · Critical Care · doi:10.1186/cc12774 · Cited by 71 · cited 1×
“Finally, because glucocorticoid sensitivity likely varies among individuals (95) and among cell types in critically ill patients (68, 81, 83) and glucocorticoid treatment may down-regulate GR- via induction of miR-124, the dosing issue is further complicated (96).”
BackgroundBoelen, A., Boorsma, J., Kwakkel, J., Wieland, C. W., Renckens, R., Visser, T. J., Fliers, E., & Wiersinga, W. M. (2008) · Thyroid · doi:10.1089/thy.2008.0090 · Cited by 70 · cited 1×
“Benefits include the expected reduction in energy expenditure with low T3 levels, or a direct effect of increased D3 activity locally in granulocytes, which could optimize bacterial killing capacity (12, 24).”
BackgroundThyroid Storm and Myxedema Coma
Nicoloff, J. T. (1985) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31002-1 · Cited by 69
Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary
Alkemade, A., Friesema, E. C., Kuiper, G. G., Wiersinga, W. M., Swaab, D. F., Visser, T. J., & Fliers, E. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02111 · Cited by 65
Langouche, L., Casaer, M., Coudyzer, W., Vanbeckevoort, D., De Dobbelaer, B., Güiza, F., Wouters, P., Mesotten, D., & Van den Berghe, G. (2013) · Critical Care · doi:10.1186/cc12191 · Cited by 63
Type 2 deiodinase and host responses of sepsis and acute lung injury
Ma, S.-F., Xie, L., Pino-Yanes, M., Sammani, S., Wade, M. S., Letsiou, E., Siegler, J., Wang, T., Infusino, G., Kittles, R. A., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0179oc · Cited by 60 · cited 1×
“associated with less sepsis susceptibility (38).”
Starling, E. H. (1923) · BMJ · doi:10.1136/bmj.2.3277.685 · Cited by 60
Richards, M. L., Caplan, R. H., Wickus, G. G., Lambert, P. J., & Kisken, W. A. (1999) · Surgery · doi:10.1016/s0039-6060(99)70011-5 · Cited by 55
Debaveye, Y., Ellger, B., Mebis, L., Van Herck, E., Coopmans, W., Darras, V., & Van den Berghe, G. (2005) · Endocrinology · doi:10.1210/en.2005-0963 · Cited by 54
Inhibition of 11β-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis
Ackermann, D., Vogt, B., Escher, G., Dick, B., Reichen, J., Frey, B. M., & Frey, F. J. (1999) · Hepatology · doi:10.1002/hep.510300303 · Cited by 51
Regulation of Tissue Iodothyronine Deiodinase Activity in a Model of Prolonged Critical Illness
Debaveye, Y., Ellger, B., Mebis, L., Darras, V. M., & Van den Berghe, G. (2008) · Thyroid · doi:10.1089/thy.2007.0287 · Cited by 50
Kanczkowski, W., Chatzigeorgiou, A., Grossklaus, S., Sprott, D., Bornstein, S. R., & Chavakis, T. (2013) · Endocrinology · doi:10.1210/en.2012-1617 · Cited by 49
Expression of the glucocorticoid receptor is decreased in experimental Staphylococcus aureus sepsis
Bergquist, M., Nurkkala, M., Rylander, C., Kristiansson, E., Hedenstierna, G., & Lindholm, C. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.07.028 · Cited by 49
Oral thyroid hormone pretreatment in left ventricular dysfunction
SIRLAK, M., YAZICIOGLU, L., INAN, M., ERYILMAZ, S., TASOZ, R., ARAL, A., & OZYURDA, U. (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2004.07.003 · Cited by 48
Stauffer, A. T., Rochat, M. K., Dick, B., Frey, F. J., & Odermatt, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201556200 · Cited by 47
Weekers, F., Michalaki, M., Coopmans, W., Van Herck, E., Veldhuis, J. D., Darras, V. M., & Van den Berghe, G. (2004) · Endocrinology · doi:10.1210/en.2003-1005 · Cited by 47
Lack of Nocturnal Serum Thyrotropin Surge after Surgery*
BARTALENA, L., MARTINO, E., BRANDI, L. S., FALCONE, M., PACCHIAROTTI, A., RICCI, C., BOGAZZI, F., GRASSO, L., MAMMOLI, C., & PINCHERA, A. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-1-293 · Cited by 45
Intensive insulin therapy in the ICU—reconciling the evidence
den Berghe, G. V. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.14 · Cited by 43
Reduced Glucocorticoid Receptor Protein Expression in Children with Critical Illness
Indyk, J. A., Candido-Vitto, C., Wolf, I. M., Venkataraman, S., Munoz, R., Saladino, R. A., Witchel, S. F., & DeFranco, D. B. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348290 · Cited by 41
Thyroid Hormone Receptor Isoform Expression in Livers of Critically Ill Patients
Thijssen-Timmer, D. C., Peeters, R. P., Wouters, P., Weekers, F., Visser, T. J., Fliers, E., Wiersinga, W. M., Bakker, O., & Berghe, G. V. D. (2007) · Thyroid · doi:10.1089/thy.2006.0164 · Cited by 39
Krinsley, J. S. (2013) · Critical Care · doi:10.1186/cc12584 · Cited by 38
Peeters, R. P., Hagendorf, A., Vanhorebeek, I., Visser, T. J., Klootwijk, W., Mesotten, D., Wouters, P. J., Koper, J. W., De Jong, F. H., Feelders, R. A., et al. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03443.x · Cited by 36 · cited 1×
“Finally, because glucocorticoid sensitivity likely varies among individuals (95) and among cell types in critically ill patients (68, 81, 83) and glucocorticoid treatment may down-regulate GR- via induction of miR-124, the dosing issue is further complicated (96).”
BackgroundVassiliadi, D. A., Ilias, Ι., Tzanela, M., Nikitas, N., Θεοδωρακοπούλου, Μ., Kopterides, P., Maniatis, N. A., Diamantakis, A., Orfanos, S. E., Perogamvros, I., et al. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2012.07.008 · Cited by 33
Glucose Dysregulation and Neurological Injury Biomarkers in Critically Ill Children
Vanhorebeek, I., Gielen, M., Boussemaere, M., Wouters, P. J., Güiza, F., Mesotten, D., & den Berghe, G. V. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0805 · Cited by 32
Derde, S., Vanhorebeek, I., Ververs, E.-J., Vanhees, I., Darras, V., Herck, E. V., Larsson, L., & den Berghe, G. V. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c03f65 · Cited by 31
Modulation of regional nitric oxide metabolism: Blood glucose control or insulin?
Ellger, B., Langouche, L., Richir, M. C., Debaveye, Y. A., Vanhorebeek, I., van Leeuwen, P. A. M., & den Berghe, G. V. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1118-4 · Cited by 31
Decreased Cytosolic Glucocorticoid Receptor Levels in Critically Ill Patients
Siebig, S., Meinel, A., Rogler, G., Klebl, F., Wrede, C. E., Gelbmann, C., Froh, S., Rockmann, F., Bruennler, T., Schoelmerich, J., et al. (2010) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1003800122 · Cited by 31
Interstitium: The next diagnostic and therapeutic platform in critical illness
Venkatesh, B., Morgan, T. J., & Cohen, J. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f24406 · Cited by 28
Debaveye, Y., Ellger, B., Mebis, L., Visser, T. J., Darras, V. M., & Van den Berghe, G. (2008) · Endocrinology · doi:10.1210/en.2007-1566 · Cited by 28
Pieracci, F. M., Hydo, L. J., Eachempati, S. R., Pomp, A., Shou, J., & Barie, P. S. (2008) · Surgical Infections · doi:10.1089/sur.2007.039 · Cited by 26
The ESC Textbook of Intensive and Acute Cardiac Care
GALIE', N., MANES, A., PALAZZINI, M., & LECI, E. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199584314.001.0001 · Cited by 24
Degradation of albumin in meningococcal sepsis
Holland, P. C., Hancock, S. W., Hodge, D., Thompson, D., Shires, S., & Evans, S. W. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05200-4 · Cited by 22
Mebis, L., Eerdekens, A., Güiza, F., Princen, L., Derde, S., Vanwijngaerden, Y.-M., Vanhorebeek, I., Darras, V. M., Van den Berghe, G., & Langouche, L. (2012) · Endocrinology · doi:10.1210/en.2011-1411 · Cited by 22 · cited 2×
“Therapeutic implications Because the available evidence now indicates that the acute “low T3 syndrome” appears to be an adaptive response partially explained by fasting, treatment is likely not indicated (22, 23).”
BackgroundPasquel, F. J., Smiley, D. D., Spiegelman, R., Lin, E., Peng, L., & Umpierrez, G. E. (2011) · Hospital Practice · doi:10.3810/hp.2011.04.397 · Cited by 17
Humphry, G. M. (1872) · BMJ · doi:10.1136/bmj.1.600.685 · Cited by 15
Baker, A. C., Chew, V. W., Green, T. L., Tung, K., Lim, D., Cho, K., & Greenhalgh, D. G. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2012.12.027 · Cited by 14 · cited 1×
“Moreover, single nucleotide polymorphisms in the GR gene, with an altered response to glucocorticoids, have been identified (97).”
BackgroundLangouche, L., Princen, L., Gunst, J., Güiza, F., Derde, S., & den Berghe, G. V. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1327605 · Cited by 7
Chung, T., Grossman, A. B., & Clark, A. J. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00101-5 · Cited by 7
Managing blood glucose in critically ill patients with or without diabetes
Finfer, S. R., & Billot, L. (2013) · Critical Care · doi:10.1186/cc12591 · Cited by 6
Sonneville, R., den Hertog, H. M., Derde, S., Güiza, F., Derese, I., den Berghe, G. V., & Vanhorebeek, I. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.01.003 · Cited by 6
Chapter 68 Endocrine emergencies
Debaveye, Y. A., Vandenbrande, J., & den Berghe, G. V. (2010) · Oxford University Press eBooks · doi:10.1093/med/9780199584314.003.0070 · Cited by 6
Weiß, M., Kron, M., Hay, B., Taenzer, M., Radermacher, P., & Georgieff, M. (2011) · Patient Safety in Surgery · doi:10.1186/1754-9493-5-5 · Cited by 4
Endocrine Aspects of Critical Care Medicine
den Berghe, G. V. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00114-3 · Cited by 3
Cited by
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
Wendon, J., Cordoba, J., Dhawan, A., Larsen, F. S., Manns, M., Nevens, F., Samuel, D., Simpson, K. J., Yaron, I., & Bernardi, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.003 · Cited by 917
Non-Thyroidal Illness in the ICU: A Syndrome with Different Faces
Van den Berghe, G. (2014) · Thyroid® · doi:10.1089/thy.2014.0201 · Cited by 316
Annane, D., Pastores, S. M., Arlt, W., Balk, R. A., Beishuizen, A., Briegel, J., Carcillo, J., Christ-Crain, M., Cooper, M. S., Marik, P. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4914-x · Cited by 220
Chatzitomaris, A., Hoermann, R., Midgley, J. E., Hering, S., Urban, A., Dietrich, B., Abood, A., Klein, H. H., & Dietrich, J. W. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00163 · Cited by 173
“The former seems to beneficially affect outcome, the latter to have an impairing effect (308).”
BackgroundLee, S., & Farwell, A. P. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c150017 · Cited by 158
“These include several medications used for treatment of critical illness, such as dopamine and glucocorticoids, that have a direct inhibitory effect on TSH secretion (11, 16).”
Metadata
- Authors
- Boonen, E., & Van den Berghe, G.
- Affiliations
- KU Leuven (BE)
- Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, B-3000 Leuven, Belgium
- ORCID
- Boonen, Eva
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-05-01
- Volume
- 99
- Issue
- 5
- Pages
- 1569-1582
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2033465735
- Semantic Scholar
- 456d12374f8ae1aecbfea66025df59a549c01121
- Cited by
- 105
- References
- 164
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 9 · 2020: 9 · 2019: 4 · 2018: 8 · 2017: 14 · 2016: 13 · 2015: 11 · 2014: 3
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- critical illness, endocrine response, hypothalamic-pituitary-thyroid axis, hypothalamic-pituitary-adrenal axis, hyperglycemia, chronic critical illness, metabolic adaptation, rehabilitation, substrate deprivation, fight-or-flight response
- MeSH terms
- Humans, Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Thyroid Gland, Critical Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.